Med19 promotes gastric cancer progression and cellular growth

Gene

Volumn 504, Issue 2, 2012, Pages 262-267

  Ding, Xiang fu ^a   Huang, Guo min ^a   Shi, Ying ^a   Li, Jun an ^a   Fang, Xue dong ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Gastric cancer; Med19; Proliferation; RNAi

Indexed keywords

MED19 PROTEIN; MEDIATOR COMPLEX; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA;

CELL LINE, TUMOR; DISEASE PROGRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MEDIATOR COMPLEX; STOMACH NEOPLASMS;

LENTIVIRUS;

EID: 84862756207     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.04.033     Document Type: Article

References (34)

1. Becerra M., Lombardia-Ferreira L.J., Hauser N.C., Hoheisel J.D., Tizon B., Cerdan M.E. The yeast transcriptome in aerobic and hypoxic conditions: effects of hap1, rox1, rox3 and srb10 deletions. Mol. Microbiol. 2002, 43:545-555.
2. Cui X., et al. Suppression of MED19 expression by shRNA induces inhibition of cell proliferation and tumorigenesis in human prostate cancer cells. BMB Rep. 2011, 44:547-552.
3. Firestein R., et al. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival. Int. J. Cancer 2010, 126:2863-2873.
4. Fondell J.D., Ge H., Roeder R.G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:8329-8333.
5. Gravalos C., Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann. Oncol. 2008, 19:1523-1529.
6. Gustafsson C.M., et al. Identification of Rox3 as a component of mediator and RNA polymerase II holoenzyme. J. Biol. Chem. 1997, 272:48-50.
7. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature 1999, 400:464-468.
8. Ito M., et al. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell 1999, 3:361-370.
9. Ji-Fu E., Xing J.J., Hao L.Q., Fu C.G. Suppression of lung cancer metastasis-related protein 1 (LCMR1) inhibits the growth of colorectal cancer cells. Mol. Biol. Rep. 2011.
10. Kang Y.K., Guermah M., Yuan C.X., Roeder R.G. The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:2642-2647.
11. Kato Y., Habas R., Katsuyama Y., Naar A.M., He X. A component of the ARC/Mediator complex required for TGF beta/Nodal signalling. Nature 2002, 418:641-646.
12. Kim J.H., Yang C.K., Heo K., Roeder R.G., An W., Stallcup M.R. CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol. Cell 2008, 31:510-519.
13. Kim N., et al. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling. J. Gastroenterol. Hepatol. 2009, 24:480-487.
14. Lewis B.A., Reinberg D. The mediator coactivator complex: functional and physical roles in transcriptional regulation. J. Cell Sci. 2003, 116:3667-3675.
15. Li M., Liu W., Zhu Y.F., Chen Y.L., Zhang B.Z., Wang R. Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer. Acta Oncol. 2006, 45:1115-1119.
16. Li Q., Peng J., Zhang G.Y. Effect of a selective COX-2 inhibitor on cell proliferation and apoptosis in human gastric cancer cell line BGC-823. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2008, 33:1123-1128.
17. Li L.H., He J., Hua D., Guo Z.J., Gao Q. Lentivirus-mediated inhibition of Med19 suppresses growth of breast cancer cells in vitro. Cancer Chemother. Pharmacol. 2011, 68:207-215.
18. Li X.H., Fang D.N., Zeng C.M. Knockdown of MED19 by short hairpin RNA-mediated gene silencing inhibits pancreatic cancer cell proliferation. Cancer Biother. Radiopharm. 2011, 26:495-501.
19. Loncle N., et al. Distinct roles for Mediator Cdk8 module subunits in Drosophila development. EMBO J. 2007, 26:1045-1054.
20. Mao X.Y., Wang X.G., Lv X.J., Xu L., Han C.B. COX-2 expression in gastric cancer and its relationship with angiogenesis using tissue microarray. World J. Gastroenterol. 2007, 13:3466-3471.
21. Matsubara J., et al. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer. Clin. Cancer Res. 2008, 14:3022-3029.
22. Park J.Y., et al. CXCL5 overexpression is associated with late stage gastric cancer. J. Cancer Res. Clin. Oncol. 2007, 133:835-840.
23. Rosenblum-Vos L.S., Rhodes L., Evangelista C.C., Boayke K.A., Zitomer R.S. The ROX3 gene encodes an essential nuclear protein involved in CYC7 gene expression in Saccharomyces cerevisiae. Mol. Cell. Biol. 1991, 11:5639-5647.
24. Senapati S., Sharma P., Bafna S., Roy H.K., Batra S.K. The MUC gene family: their role in the diagnosis and prognosis of gastric cancer. Histol. Histopathol. 2008, 23:1541-1552.
25. Shimamura T., et al. Overexpression of MUC13 is associated with intestinal-type gastric cancer. Cancer Sci. 2005, 96:265-273.
26. Sun M., et al. MED19 promotes proliferation and tumorigenesis of lung cancer. Mol. Cell. Biochem. 2011, 355:27-33.
27. van Rees B.P., et al. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J. Pathol. 2002, 196:171-179.
28. Vijayvargia R., May M.S., Fondell J.D. A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression. Cancer Res. 2007, 67:4034-4041.
29. Wang T., Hao L., Feng Y., Wang G., Qin D., Gu G. Knockdown of MED19 by lentivirus-mediated shRNA in human osteosarcoma cells inhibits cell proliferation by inducing cell cycle arrest in the G0/G1 phase. Oncol. Res. 2011, 19:193-201.
30. Wright P.A., Quirke P., Attanoos R., Williams G.T. Molecular pathology of gastric carcinoma: progress and prospects. Hum. Pathol. 1992, 23:848-859.
31. Wu W.H., Hampsey M. Transcription: common cofactors and cooperative recruitment. Curr. Biol. 1999, 9:R606-R609.
32. Zhang X.L., et al. Comparative study on overexpression of HER2/neu and HER3 in gastric cancer. World J. Surg. 2009, 33:2112-2118.
33. Zhang H., et al. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth. Urol. Oncol. 2011, 10.1016/j.urolonc.2010.10.003.
34. Zou S.W., Ai K.X., Wang Z.G., Yuan Z., Yan J., Zheng Q. The role of Med19 in the proliferation and tumorigenesis of human hepatocellular carcinoma cells. Acta Pharmacol. Sin. 2011, 32:354-360.